These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38294338)

  • 21. The Effect of Antiepileptic Drugs on Cognition: Patient Perceived Cognitive Problems of Topiramate versus Levetiracetam in Clinical Practice.
    Bootsma HP; Aldenkamp AP; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
    Epilepsia; 2006; 47 Suppl 2():24-7. PubMed ID: 17105455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanisms of topiramate and its clinical value in epilepsy.
    Bai YF; Zeng C; Jia M; Xiao B
    Seizure; 2022 May; 98():51-56. PubMed ID: 35421622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Psychiatric Symptoms of Patients With Epilepsy: Characteristics of Psychiatric Adverse Events by Novel Antiepileptic Medications].
    Kanemoto K; Nishida T; Hasegawa N
    Brain Nerve; 2023 Apr; 75(4):375-389. PubMed ID: 37037510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial levetiracetam versus valproate monotherapy in antiseizure medicine (ASM)-naïve pediatric patients with idiopathic generalized epilepsy with tonic-clonic seizures.
    Abdelmesih SK; Elkhateeb N; Zakaria M; Girgis MY
    Seizure; 2021 Oct; 91():263-270. PubMed ID: 34246881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiepileptics topiramate and levetiracetam alleviate behavioral deficits and reduce neuropathology in APPswe/PS1dE9 transgenic mice.
    Shi JQ; Wang BR; Tian YY; Xu J; Gao L; Zhao SL; Jiang T; Xie HG; Zhang YD
    CNS Neurosci Ther; 2013 Nov; 19(11):871-81. PubMed ID: 23889921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.
    Marson AG; Appleton R; Baker GA; Chadwick DW; Doughty J; Eaton B; Gamble C; Jacoby A; Shackley P; Smith DF; Tudur-Smith C; Vanoli A; Williamson PR
    Health Technol Assess; 2007 Oct; 11(37):iii-iv, ix-x, 1-134. PubMed ID: 17903391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topiramate: efficacy and tolerability in children according to epilepsy syndromes.
    Mikaeloff Y; de Saint-Martin A; Mancini J; Peudenier S; Pedespan JM; Vallée L; Motte J; Bourgeois M; Arzimanoglou A; Dulac O; Chiron C
    Epilepsy Res; 2003 Mar; 53(3):225-32. PubMed ID: 12694931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic review.
    Steinhoff BJ; Klein P; Klitgaard H; Laloyaux C; Moseley BD; Ricchetti-Masterson K; Rosenow F; Sirven JI; Smith B; Stern JM; Toledo M; Zipfel PA; Villanueva V
    Epilepsy Behav; 2021 May; 118():107939. PubMed ID: 33839453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
    Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
    Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topiramate in patients with learning disability and refractory epilepsy.
    Kelly K; Stephen LJ; Sills GJ; Brodie MJ
    Epilepsia; 2002 Apr; 43(4):399-402. PubMed ID: 11952770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in antiseizure medication prescription patterns among all adults, women, and older adults with epilepsy: A German longitudinal analysis from 2008 to 2020.
    Hochbaum M; Kienitz R; Rosenow F; Schulz J; Habermehl L; Langenbruch L; Kovac S; Knake S; von Podewils F; von Brauchitsch S; Hamacher M; Strzelczyk A; Willems LM
    Epilepsy Behav; 2022 May; 130():108666. PubMed ID: 35339390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Sudell M; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD012065. PubMed ID: 27922722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of antiseizure drug-related adverse reactions from the electronic health record using the common data model.
    Choi SA; Kim H; Kim S; Yoo S; Yi S; Jeon Y; Hwang H; Kim KJ
    Epilepsia; 2020 Apr; 61(4):610-616. PubMed ID: 32162687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Short-term and long-term efficacy of topiramate in refractory generalized epilepsy of children].
    Watanabe T; Oyanagi R; Minagawa K
    No To Hattatsu; 2011 May; 43(3):223-7. PubMed ID: 21638908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment patterns in women of childbearing age and pregnant women with epilepsy in Poland between the years 2019 and 2022-A nationwide population-based cohort study.
    Wójcik K; Kruk M; Koń B; Słowik A; Bosak M
    Seizure; 2024 Feb; 115():75-80. PubMed ID: 38232647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiseizure medications as migraine preventatives: a call for action for a teratogenic and neurodevelopmental risk removal.
    Wells-Gatnik W; Martelletti P
    Expert Opin Drug Saf; 2023; 22(9):777-781. PubMed ID: 37575009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy.
    Kim DW; Lee SY; Shon YM; Kim JH
    Epilepsia; 2013 Oct; 54(10):e146-9. PubMed ID: 23980720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of epilepsy in adults: expert opinion, 2005.
    Karceski S; Morrell MJ; Carpenter D
    Epilepsy Behav; 2005 Sep; 7 Suppl 1():S1-64; quiz S65-7. PubMed ID: 16102515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aggravation of partial seizures by antiepileptic drugs: is there evidence from clinical trials?
    Somerville ER
    Neurology; 2002 Jul; 59(1):79-83. PubMed ID: 12105311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term effectiveness and tolerability of topiramate in children with epilepsy under the age of 2 years: 4-year follow-up.
    Kim JM; Kwon S; Seo HE; Choe BH; Cho MH; Park SP
    J Korean Med Sci; 2009 Dec; 24(6):1078-82. PubMed ID: 19949663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.